|
C2CD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.079200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.513600E-01 |
| Normal-vs-Stage2 |
7.044600E-01 |
| Normal-vs-Stage3 |
1.320030E-02 |
| Normal-vs-Stage4 |
1.109820E-01 |
| Stage1-vs-Stage2 |
9.386000E-01 |
| Stage1-vs-Stage3 |
8.337100E-03 |
| Stage1-vs-Stage4 |
1.497200E-01 |
| Stage2-vs-Stage3 |
7.308100E-02 |
| Stage2-vs-Stage4 |
3.306000E-01 |
| Stage3-vs-Stage4 |
4.365200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.861570E-01 |
| Normal-vs-AfricanAmerican |
8.372200E-01 |
| Normal-vs-Asian |
7.549200E-01 |
| Caucasian-vs-AfricanAmerican |
5.853600E-01 |
| Caucasian-vs-Asian |
4.999200E-01 |
| AfricanAmerican-vs-Asian |
9.677600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.566100E-02 |
| Normal-vs-Female |
3.638200E-01 |
| Male-vs-Female |
1.980450E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.062600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.591450E-01 |
| Normal-vs-Age(61-80Yrs) |
5.164000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.765000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.750500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.848030E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.771510E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.346800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.578400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.578200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.353700E-04 |
| Classical-VS-Follicular |
1.955780E-02 |
| Classical-VS-Other |
7.989000E-01 |
| Classical-VS-Normal |
9.296200E-01 |
| Tall-VS-Follicular |
1.625000E-01 |
| Tall-VS-Other |
2.610000E-01 |
| Tall-VS-Normal |
3.001800E-03 |
| Follicular-VS-Other |
2.971600E-01 |
| Follicular-VS-Normal |
6.328200E-02 |
| Other-VS-Normal |
8.195200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.949800E-01 |
| Normal-vs-N1 |
4.164200E-02 |
| N0-vs-N1 |
3.015600E-01 |
|
|
